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a  b  s  t  r  a  c  t
Recently,  transcatheter  device  occlusion  has  become  the  ﬁrst choice  treatment  for adult  persistent  duc-
tus arteriosus  (PDA).  However,  various  complications  such  as  atrial  ﬁbrillation  requiring  anticoagulation,
pulmonary  hypertension,  and  ventricular  dysfunction  may  challenge  the  interventionist.  We  report  a
61-year-old  patient  with  a large PDA  complicated  by  left ventricular  dysfunction,  atrial  ﬁbrillation,  and
left  atrial  thrombus.  Computed  tomography  documented  the PDA  of  Krichenko  type  A with  the  nar-
rowest  diameter  of 8 mm.  We  successfully  closed  the PDA  using  an  Amplatzer  duct occluder  under
anticoagulation  with  wafarin.  His  post-operative  course  was  complicated  by  ventricular  tachycardia  and
deteriorating  left ventricular  pump  function.  Although  endomyocardial  biopsy  from  the  left  ventricle
showed  myocardial  hypertrophy  and  interstitial  ﬁbrosis,  possibly  caused  by  chronic  volume  overload,
left  ventricular  pump  function  improved  dramatically  with  restoration  of  sinus  rhythm  during  follow-up.
Left ventricular  dysfunction,  even  when  associated  with  histological  changes,  may  be  nearly  normalized
by  volume  unloading  in  an  adult  with  a  large  PDA.
<Learning  objective:  Transcatheter  device  occlusion  has  become  the  ﬁrst  choice  for  adult  persistent  duc-
tus  arteriosus  (PDA).  It is  important  to note  various  complications  associated  with  transcatheter  occlusion
of PDA  in  adult,  such  as  arrhythmia,  pulmonary  hypertension,  and  ventricular  dysfunction.  Temporally
dysfunction  of left ventricular  (LV)  systolic  performance  usually  occurs  following  PDA  closure,  because  of
reduced  muscle  ﬁber  stretch  by the sudden  reduction  in  LV  volume  overload  and  increased  LV  afterload.
Although  histological  remodeling  of LV  may  be caused  by  volume  overload  due  to  signiﬁcant  left-to-right
shunt  in adults,  volume  unloading  can,  not  only  prevent  further  deterioration  of  LV  function,  but  also  may
 of  ar
2  Japalso reverse  the  substrate
© 201
ntroduction
Chronic volume overload in adult patients with persistent duc-
us arteriosus (PDA) may  impair left ventricular (LV) function which
ay  be further compromised by various ventricular arrhythmias.
e report a 61-year-old man  with a large PDA complicated by
erious arrhythmia and LV dysfunction following transcatheter
cclusion using an Amplatzer duct occluder (ADO). Although
ndomyocardial biopsy showed extensive histological changes in
is myocardium, his LV pump function became almost normal
ix months after restoration of sinus rhythm.
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Case report
A PDA was  detected in a 61-year-old man  when he underwent
catheter ablation for ventricular tachycardia of right ventricu-
lar outﬂow origin, 8 years before his present illness. He was
referred to our hospital because of recurrent syncope, dyspnea
on exertion, leg edema, and chronic atrial ﬁbrillation despite
multiple medications including digoxin, furosemide, angiotensin
receptor blockers (ARB), aprindine, propafenone, verapamil, and
warfarin. His New York Heart Association (NYHA) functional class
was II–III, while physical examination revealed an SpO2 of 98%,
blood pressure 113/68 mmHg, a grade 3/6 continuous murmur
over the upper left sternal border, and bounding pulses. Labora-
tory data were non-speciﬁc for complete blood count, electrolytes,
and renal and hepatic proﬁles. A chest X-ray showed marked
cardiomegaly and increased pulmonary vascularity (Fig. 1a). His
vier Ltd. All rights reserved.









aFig. 1. Chest X-ray ﬁndings before patent ductus arteriosus (PDA) closure (a), 24
lectrocardiogram documented atrial ﬁbrillation with a wide QRS,
nd a ventricular rate of around 80 beats/min (Fig. 2a). Doppler
chocardiograms showed a continuous ﬂow from descending aorta
o the main pulmonary artery, while the left atrium and the left
entricle were dilated (LV internal diastolic dimension, LVIDd,
7 mm),  and left ventricular ejection fraction (LVEF) decreased
ig. 2. Electrocardiograms before patent ductus arteriosus (PDA) closure (a), 24 h
fter PDA closure (b), and 6 months after PDA closure (c).r PDA closure (b), and 6 months after PDA closure (c). CTR, cardio-thoracic ratio.
to 0.50. There was  aortic, mitral, and tricuspid regurgitation of
mild degree, while tricuspid regurgitation velocity was  3.5 m/s
which suggested mild pulmonary hypertension. Transesophageal
echocardiography showed an old thrombus attached to the left
atrial appendage. Computed tomography documented a heavily
calciﬁed PDA of Krichenko type A with the narrowest diameter
of 8 mm (Fig. 3). Considering the following factors, (1) stability of
the thrombus in the appendage, (2) heavy calciﬁcation of the duct
which would necessitate cardiopulmonary bypass and patch aor-
toplasty for surgical repair, and (3) chronic multiple arrhythmias
which may require extensive electrophysiological management,
we chose transcatheter closure using ADO rather than surgery.
The procedure was performed under general anesthesia with tra-
cheal intubation to monitor the thrombus and the shunt through
PDA by transesophageal echocardiography. Cardiac catheterization
demonstrated pulmonary to systemic ﬂow ratio of 4.8 complicated
by mild pulmonary hypertension (mean pulmonary arterial pres-
sure of 25 mmHg), while systemic arterial pressure was  relatively
low being 66/26 mmHg. LV end diastolic pressure was 8 mmHg.
Considering the risk of hemolysis associated with a residual leak
in a patient taking warfarin, we  decided to close the PDA implant-
ing a slightly oversized ADO (9-PDA-009) with the usual technique.
We used heparin to keep activated clotting time above 200 s dur-
ing the procedure. Although there was a trivial leak through the
device immediately after deployment, it disappeared within 24 h.
Aortic pressure just after PDA occlusion was not recorded, how-
ever, blood pressure after the procedure was  stable at 98/51 mmHg.
Transesophageal echocardiography showed the thrombus was sta-
ble in the left atrial appendage before and after the procedure.
His postoperative course remained uneventful during the ﬁrst
24 h; however, subsequently his hemodynamic condition deteri-
orated with a wide QRS tachycardia and a ventricular rate over
170 beats/min. Although LVEF remained stable around 50%, blood
pressure dropped to around 60 mmHg. Consequently, he needed
dopamine and dobutamine, 3 g/kg/min each, to maintain an ade-
quate cardiac output (Figs. 1 and 2b). As multiple antiarrhythmic
medications with amiodarone and landiolol hydrochloride were
ineffective, cardioversion was performed 4 days after PDA  occlu-
sion. The rhythm returned to atrial ﬁbrillation similar to that before
PDA occlusion, and his hemodynamic condition and symptoms
were stabilized after cardioversion.
Electrophysiological study (EPS) was  performed 21 days after
PDA occlusion. Ventricular tachycardia with a left bundle branch
block pattern and inferior axis was  reproducibly induced by
programmed electrical stimulation. The ventricular tachycardia
was similar to the wide QRS tachycardia documented previously.
























sFig. 3. Computed tomography documented patent ductus a
lectro-anatomical mapping during the tachycardia showed an
arly activation point originating from the posterolateral aspect of
he right ventricular outﬂow tract, where double potentials and
ragment potentials were detected. We  could not identify a site
here the pace map  perfectly matched the ventricular tachycardia.
ubsequently, we performed catheter ablation targeting the double
otentials and fragment potentials, however, it was only partially
uccessful. Considering the previous history of syncope, and the
ersisting highly reproducible induction of ventricular tachycardia
fter catheter ablation despite administration of amiodarone, we
ecided to implant a cardiac deﬁbrillator (ICD). Endomyocardial
iopsy from the left ventricle at the same time as the EPS showed
ypertrophy of myocardium, bizarre nuclei, and severe intersti-
ial ﬁbrosis, while histological changes in the right ventricle were
nremarkable (Fig. 4).
Two months later, echocardiography showed slight reduction
n his LVEF to 39% [LVIDd 43.3 mm,  LV internal systolic dimension
LVIDs) 35.3 mm],  however later his symptoms were improving fol-
owing restoration of sinus rhythm. Six months after discharge,
chocardiography showed a dramatic recovery of LVEF to 68%,
hile LVIDd had decreased (LVIDd 43.5 mm,  LVIDs 27.0 mm).  His
YHA functional class is now I. He has remained in sinus rhythm
ig. 4. Endomyocardial biopsy from the left ventricle (hematoxylin and eosin stain)
howed hypertrophy of myocardium, bizarre nuclei, and severe interstitial ﬁbrosis.sus of Krichenko type A with narrowest diameter of 8 mm.
without discharge of his ICD for 17 months under medication with
amiodarone, ARB, and diuretics (Figs. 1 and 2c).
Discussion
Recently, transcatheter device occlusion has become the ﬁrst
choice treatment for adult PDA. However, various complications
such as atrial ﬁbrillation requiring anticoagulation [1],  pulmonary
hypertension [2,3], and ventricular dysfunction [4] may  challenge
the interventionist. We  closed a large PDA in an adult complicated
by LV dysfunction, atrial ﬁbrillation, and left atrial thrombus using
ADO. Although the PDA was completely closed despite warfarin
anticoagulation, the postoperative course was complicated by dete-
riorating ventricular function and ventricular tachycardia, which
required multiple medications, cardioversion, and ICD implanta-
tion.
There are several publications describing subsequent deterio-
ration of LV systolic function after PDA closure [4–10]. Reduced
muscle ﬁber stretch by the sudden reduction in LV volume over-
load and increased LV afterload are proposed explanations of such
hemodynamic worsening [6,9]. Furthermore, deterioration after
PDA closure is more pronounced in adults than in children [6,8],
because in adults the left ventricle has been subjected to prolonged
remodeling induced by the volume overload resulting in structural
changes in the LV myocardium, and irreversible deterioration of
LV contractility [8]. Actually, endomyocardial biopsy ﬁndings in
our patient showed histological remodeling which supports the
suggested pathophysiological mechanism referred to.
Temporary ventricular dysfunction after PDA occlusion might
have been predicted as reported previously [4–10], however, seri-
ous arrhythmias as complicated our patient’s course are relatively
uncommon. Pass et al. [11] showed that new cardiac arrhythmias
requiring cardioversion or medication occurred in 0.5% of patients
after PDA closure. Nevertheless our patient’s course was  compli-
cated by such critical events 24 h after PDA closure, he underwent
remarkable symptomatic improvement associated with restored
sinus rhythm, and signiﬁcant reduction in LV dimensions was sub-
sequently observed. Although the origin of VT in EPS was right
ventricular outﬂow, the histologial changes in the right ventricle
were unremarkable. Furthermore, another ventricular tachycardia,
whose origin could not be determined in that session, was  highly
reproducible even after catheter ablation despite administration of
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igniﬁcant left-to-right shunt may  have caused atrial ﬁbrillation,
nd at least one of ventricular tachycardias, associated with remod-
ling of the left heart ventricle in our patient. Although further
nvestigation is needed to prevent and to manage subsequent dete-
ioration of LV function in these patients, we consider that sufﬁcient
ontrol of heart failure if existing previously, and multidisciplinary
herapy is important.
Brockmeier et al. [1].  reported late recanalization of PDA follow-
ng complete closure by ADO in an adult who was taking warfarin
or atrial ﬁbrillation. Although our patient was  also taking war-
arin, we successfully occluded the PDA without leaving a residual
hunt. We chose a slightly over sized ADO for the purpose of pre-
enting residual leak; however, further clinical data are required to
onclude whether such oversizing would be uniformly effective in
reventing residual leaks in a patient taking warfarin.
onclusion
We closed a large PDA using ADO in an adult whose condition
as complicated by LV dysfunction, atrial ﬁbrillation, and left atrial
hrombus. Chronic volume overload associated with a large PDA
ay lead to deterioration of LV function and trigger ventricular
rrhythmias not only before but also after PDA closure, particu-
arly in adults. Volume unloading in such a patient cannot only
revent further deterioration of LV function but may  also reverse
he substrate of atrial and ventricular arrhythmia.
cknowledgmentsWe  thank Dr Peter M.  Olley, Professor Emeritus of Pedi-
trics, University of Alberta, and Dr Setsuko Olley for language
onsultation.
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